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ABSTRACT
With their capability to undergo unlimited self-renewal
and to differentiate into all cell types in the body, human
embryonic stem cells (hESCs) hold great promise in
human cell therapy. However, there are limited tools for
easily identifying and isolating live hESC-derived cells.
To track hESC-derived neural progenitor cells (NPCs),
we applied homologous recombination to knock-in the
mCherry gene into the Nestin locus of hESCs. This
facilitated the genetic labeling of Nestin positive neural
progenitor cells with mCherry. Our reporter system
enables the visualization of neural induction from
hESCs both in vitro (embryoid bodies) and in vivo (ter-
atomas). This system also permits the identiﬁcation of
different neural subpopulations based on the intensity
of our ﬂuorescent reporter. In this context, a high level of
mCherry expression showed enrichment for neural
progenitors, while lower mCherry corresponded with
more committed neural states. Combination of mCherry
high expression with cell surface antigen staining
enabled further enrichment of hESC-derived NPCs.
These mCherry+ NPCs could be expanded in culture and
their differentiation resulted in a down-regulation of
mCherry consistent with the loss of Nestin expression.
Therefore, we have developed a ﬂuorescent reporter
system that can be used to trace neural differentiation
events of hESCs.
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INTRODUCTION
Human embryonic stem cells (hESCs) undergo unlimited
self-renewal and retain pluripotency to differentiate into all
cell types of the body, making them invaluable tools for
development of cellular therapeutics (Fu and Xu, 2011).
Modeling human disease has further become possible with
advances in genetic modiﬁcation in hESCs either through
homologous recombination (Song et al., 2010; Hockemeyer
et al., 2011) or gene knockdown (Ordonez et al., 2012), as
well as reprogramming of cells having disease-causing
mutations into an ESC-like state (human induced pluripotent
stem cells or hiPSCs) (Unternaehrer and Daley, 2011). Given
the limitation of using mouse systems to develop human
therapeutics, the use of these approaches can provide more
physiologically relevant insight into disease pathology and
help to identify more efﬁcacious drug targets. These
approaches additionally permit disease modeling of tissues
that are previously unattainable or that show pathologies too
advanced in donor tissues. This includes studies on the
mechanisms underlying neuronal degeneration associated
with central nervous system (CNS) diseases (e.g. Parkin-
son’s, Alzheimer’s or Amyotrophic lateral sclerosis).
Studies using human pluripotent stem cell derived neu-
rons to model these diseases or generate neural tissue
replacements rely upon the effectiveness of protocols that
recapitulate normal embryonic development to direct the
differentiation of hESCs into the neural cell types afﬂicted by
the disease (Aas et al., 1996). A key step in this process is to
differentiate hESCs into neural stem cells (NSCs) that can
be further differentiated into neurons, astrocytes and glia.
While signiﬁcant progress has been made in improving the
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differentiation of hESCs into NSCs (Reubinoff et al., 2001;
Itsykson et al., 2005; Wu et al., 2007; Chambers et al.,
2009), this step remains an imperfect process with resulting
cultures comprising a mixture of undifferentiated ESCs,
NSCs, neurons, glia and non-CNS cell types including
neural crest. Subsequent differentiation of these mixed cul-
tures would fail to generate single pure lineages needed for
transplantation, modeling or population based gene
expression studies (e.g. RNA-seq).
To circumvent these issues, several groups have had
success in using combinatorial cell surface marker staining
to enrich for NSCs (Yuan et al., 2011; Israel et al., 2012).
However this method requires further sorting strategies for
continued monitoring of resultant cell differentiation states.
Promoter-based viral reporter systems for the neural pro-
genitor marker Nestin has also been used to speciﬁcally
label NSCs within the human fetal brain and could be used to
purify these cells for expansion or for further differentiation
both in culture and following transplantation (Keyoung et al.,
2001). Several groups have used Nestin reporter systems to
identify and track neural progenitors both in vivo and in vitro
(Sawamoto et al., 2001; Lenka et al., 2002; Mignone et al.,
2004; Noisa et al., 2010). These transgenic or viral based
strategies, however, involve integration of the exogenous
DNA into random genomic loci that can modulate the pro-
moter activity, depending on the epigenetic state around the
integration site. To address this issue, we decided to gen-
erate knock-in cell lines using a Nestin-based ﬂuorescent
reporter system that would permit not only a simpler sorting
strategy for isolating NPCs/NSCs but also would enable their
live tracking during expansion or differentiation. Unlike
transgenic approaches (Placantonakis et al., 2009), this
system would ensure reporter expression speciﬁcally driven
by the endogenous Nestin promoter and/or enhancer, and
would not introduce any other genetic alterations that arise
from random integration strategies. This would permit spe-
ciﬁc mCherry expression during neural differentiation of
hESCs and the ability to generate enriched NSC cultures
where multi-potentiality could be easily monitored. These
cells will provide a unique opportunity for studies requiring
purer neural cultures and live cell tracking, including trans-
plantation, disease modeling or whole transcriptome analy-
ses (Peljto and Wichterle, 2011).
RESULTS
Generation of a knock-in Nestin reporter cell line
We have recently developed a bacterial artiﬁcial chromo-
some (BAC) based targeting strategy that enables a high
efﬁciency of homologous recombination in hESCs (Song
et al., 2010). To knock-in the mCherry coding region into the
Nestin locus, we constructed a BAC targeting vector in which
the ATG of one endogenous Nestin allele was replaced with
that of mCherry (Fig. 1A and 1B). In order to screen for
homologous recombinants, one homologous arm of the BAC
vector was shortened to 6.5 kb. Recombinants were then
screened by Southern blotting to identify both the 8.8 kb
germline band and the 11.2 kb mutant band (Fig. 1B). The
LoxP-ﬂanked selection marker cassette (CAG-Neo) was
subsequently excised from the genome (Fig. 1C) through
transient expression of the Cre enzyme (Song et al., 2007).
Knock-in hESCs showed normal karyotypes (Fig. 2A) and
retained the potential to differentiate into all three germ lay-
ers including neuroectoderm (Fig. 2B and 2C). Furthermore,
mCherry-positive neural-like cells were found to migrate from
teratoma tissues when they were cultured in neural pro-
genitor medium (Fig. 2F–H). Therefore, our knock-in cell line
may provide a means for monitoring the formation of neural
lineages during early hESC differentiation.
mCherry ﬂuorescence follows Nestin expression
dynamics
To further validate whether our genetic tagging of the Nestin
locus could allow tracing of neural differentiation from
hESCs, Nestin:mCherry hESCs were differentiated with an
established embryoid body (EB) neural induction protocol
(Reubinoff et al., 2001; Zhang et al., 2001). mCherry positive
cells could be observed soon after EB treatment with neural
induction medium coincident with the expected emergence
of neural progenitors (Fig. 3A). Further, mCherry positive
cells were found to migrate out from attached EBs (Fig. 3B
and 3C) and rapidly expanded to conﬂuence similarly to that
observed for teratoma tissues (Fig. 2F–H). This conﬁrms that
our Nestin:mCherry reporter system can monitor neural
speciﬁcation from both in vitro and in vivo differentiated
hESCs.
Following out-migration from EB or teratoma tissues,
mCherry positive cells displayed properties consistent with
neural progenitor cells. They could be further expanded in
culture for several passages (data not shown); showed sig-
niﬁcant proliferation as indicated by Ki-67 staining (Fig. 3D);
and co-expressed endogenous Nestin (Fig. 3E). Further-
more, high mCherry expression was localized to neural
rosette-like structures, as was previously reported for a
transgenic Nestin reporter (Noisa et al., 2010), and co-
localized with the neural stem cell marker Sox2 (Fig. 3F).
Therefore, mCherry expression can faithfully label Nestin
positive cycling progenitors during differentiation of hESCs
into the neural lineage both in vitro and in vivo.
mCherry levels dropped during NPC differentiation
While our results indicate that the knock-in of mCherry into
the Nestin locus recapitulates its endogenous expression,
we next sought to deﬁne whether mCherry speciﬁcally labels
neural progenitors. To do address this, mCherry positive
cells were characterized using ﬂow cytometry (Figs. 4A and
5). Interestingly, two different fractions showing low and high
mCherry expression were revealed with global passaging of
neural cultures coincident with an emerging population of
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CD44 positive cells (Fig. 4A) representing more differenti-
ated neural cell types (Liu et al., 2004). Continued culture in
this manner resulted in the progressive loss of mCherry
expression over several passages (data not shown). Our
results are consistent with mCherryLo cells potentially rep-
resenting more committed neural cell types as has been
previously reported for a transgenic hESC system (Noisa
et al., 2010). In fact, mouse Nestin reporters exhibited
gradient levels of reporter activity during differentiation, with
high levels associated with neural stem cells, lower levels
observed in more differentiated yet dividing neuronal pro-
genitors and ﬁnally little to no activity in fully differentiated
neurons (Sawamoto et al., 2001; Lenka et al., 2002; Mig-
none et al., 2004). Consistently, mCherry expression was
lost in terminally differentiated neurons that were labeled
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Figure 1. Nestin:mCherry knock-in strategy. (A) The germline conﬁguration of the Nestin locus in hESCs showing: the exon
containing the initiation ATG; the germline ScaI fragment; the probe used for Southern blot analysis; and the BAC targeting vector
containing the mCherry (RFP) expression cassette together with the LoxP-ﬂanked selection marker. (B) Insertion of this cassette into
the Nestin exon replaced the initiation ATG of mCherry with that of the Nestin gene and generated an altered ScaI fragment size
corresponding to the targeted allele. (C) The transient expression of Cre led to the excision of the selection marker allowing normal
expression of the mCherry according to the endogenous Nestin gene. (D) Southern blot analysis of the targeted hESCs. Genomic
DNA was digested with ScaI and hybridized to the probe indicated in (A and B). The location of the targeted and wild-type fragments
are indicated. Lanes 1 and 3: hESCs with random integration of the targeting construct. Lanes 2 and 4: homologous recombinants.
(E) Southern blot analysis of the knock-in hESCs showing that the selection marker was excised from the targeted allele by LoxP/Cre-
mediated deletion. Genomic DNA was digested with ScaI and probed with the same targeting probe shown in (A, C).
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addition, mCherryHi NPCs could be differentiated into both
GFAP+ astrocytes and Tuj1+ neurons (Fig. 4D and 4E),
conﬁrming their multipotency. Therefore, our results dem-
onstrate that mCherry levels correspond with endogenous
Nestin expression, speciﬁcally labeling neural progenitors
and lost upon their further differentiation.
One signiﬁcant advantage to the labeling of NPCs with
mCherry would be the potential for sorting and enriching this
population. Furthermore, given the potential heterogeneity of
neural progenitors in terms of stage of commitment and
potentiality, it would be advantageous to speciﬁcally isolate
or enrich bone ﬁde neural stem cells. To determine the
speciﬁcity of mCherry to NSCs or NPCs compared to more
committed cell lineages, we used cell surface markers that
highlight these different neural subpopulations. Previous
reports have shown the use of multiple surface markers to
identify NSCs based on a CD184+CD271-CD44-CD24+
staining signature (Yuan et al., 2011). Both CD271 and CD44
identify undifferentiated hESCs, as well as neural contami-
nants including neural crest stem cells, peripheral neural
cells, more differentiated neuronal cell types, astrocyte pro-
genitors and glia (Morrison et al., 1999; Luo et al., 2002; Liu
et al., 2004; Lee et al., 2007). Alternatively, both CD184 and
CD24 have been shown to be expressed on the surface of
NSCs. Consistent with mCherry high expressers represent-
ing a more neural stem cell state, the CD184+CD44-CD24+
population localized more within the mCherryHi expressing
cells in contrast to the CD184-CD24- population (Fig. 5).
Furthermore, the CD271-CD44-CD24+ cells also mapped
more to the mCherryHi expressers unlike a similar CD24-
population (Fig. 5). These results indicate that mCherry high
expression is in part predicative of a stem cell state, but is
not speciﬁc to this population (Fig. 5). This is likely the result
of continued high Nestin expression in more committed
neural progenitors as well as a potential lag in the mCherry
expression compared to endogenous Nestin that is a result
of their differing protein stabilities.
mCherry sorting strategy for NSC enrichment
While high mCherry expression occurs in neural stem cells
(Fig. 3F), it in itself is not sufﬁcient to fully purify this fraction
from the global population. In order to achieve this,
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Figure 2. Nestin-mCherry knock-in hESCs. (A) Twenty metaphase cells of the knock-in hESCs were examined and exhibited
normal karyotypes. (B) Knock-in hESCs formed well-differentiated teratomas in SCID mice. Cells of each of the three germ layers
were identiﬁed in the teratomas including: (C) ectoderm (R, neural rosette); (D) mesoderm (C, cartilage); (E) endoderm (GE, gut-like
epithelium). Out migration of mCherry positive neural cells were observed from teratomas formed by knock-in hESCs on day 1 (F–F′),
day 3 (G–G′) and day 7 (H–H′) following attachment in NPC medium.
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surface marker staining. Interestingly, neural cultures that
were gated on the mCherryHi expression and that were
additionally either CD271-CD44- or CD44-CD184+ (Fig. 6A)
were almost entirely CD24+ when neural cells were col-
lected directly from induced EBs. This indicates a redun-
dancy for this marker at this stage in neural differentiation.
However, this trend was not necessarily observed after
passaging of the total population, likely due to the sponta-
neous differentiation of NPCs (data not shown). Therefore,
these results indicate that mCherryHi can substitute for the
CD24+ staining when isolating NSCs directly from induced
EBs, enabling a simpler sorting strategy for these cells.
Consistently, the sorted CD184+CD44-CD271- population,
which was found to map to a mCherryHi population
(Fig. 6B), showed signiﬁcant further enrichment of the NSC
markers Sox1, Sox2 and Pax6 over the mCherryHi popu-
lation alone (Fig. 6C). Use of dual SMAD inhibitors Noggin
and SB431542 during neural induction (Chambers et al.,
2009) was found to signiﬁcantly increase the number of
NSCs sorted and showed a further increase in Sox1 and
Pax6 expression levels in the enriched mCherryHi popula-
tion (data not shown). Therefore, these results indicate that
the combination of mCherryHi with a more limited surface
marker sorting strategy that excludes CD24 can be sufﬁ-
cient to signiﬁcantly enrich for NSCs. Furthermore, substi-
tuting CD24 for mCherry expression provides the distinct
advantage of being able to further monitor the differentia-
tion status of the NPC culture and permits tracking of ter-
minal differentiation events.
DISCUSSION
Our studies demonstrate a knock-in approach that can be
used together with existing strategies of purifying NPCs/
NSCs derived from hESCs while additionally providing a


























Figure 3. mCherry labeled Nestin positive neural progenitors derived from knock-in hESCs. Neural induction of embryoid
bodies (EB) and corresponding mCherry expression on day 1 (A–A′), day 3 (B–B′) and day 7 (C–C′) following EB attachment.
mCherry positive neural progenitor cells cultured in NPC medium showed active proliferation as indicated by Ki-67 staining (D–D′′),
co-expressed Nestin (E–E′′) and co-localized with Sox2 in rosette-like structures (F–F′′).
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Transgenic or viral Nestin reporters have been widely used
to label neural progenitors (Keyoung et al., 2001; Sawam-
oto et al., 2001; Lenka et al., 2002; Mignone et al., 2004;
Noisa et al., 2010) and Nestin positivity remains an
important marker identifying hESC-derived NSCs (Reubi-
noff et al., 2001; Zhang et al., 2001; Itsykson et al., 2005;
Joannides et al., 2007; Chambers et al., 2009). Our
transgene-free Nestin:mCherry reporter hESC line provides
the unique ability to monitor the differentiation status of our
cultures with the sensitivity to distinguish high and low sub-
populations of Nestin expression and without requiring
Nestin immunostaining. While mCherryLo cells likely corre-
spond to more committed neural lineages or non-neural
contaminants, the mCherryHi population appears to enrich
for neural progenitors with multi-lineage capabilities. Fur-
thermore, the combination of mCherryHi with CD184, CD44
and CD271 surface marker staining permitted signiﬁcant
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Figure 4. mCherry intensity is consistent with Nestin expression dynamics. (A) FACS analysis for mCherry expression levels in
Hues9 hESCs or neural cultures derived from Nestin:mCherry knock-in Hues9 hESCs. Neural cultures that were out-migrating from
EBs (Passage 0) or were passaged one time (Passage 1) were either stained with FITC isotype control or FITC labeled anti-CD44
antibody. Both mCherry low expressing fractions and CD44 positive fractions are indicated. (B) mCherryHi population differentiates
into synapsin positive neurons as shown by Syn:GFP reporter lentivirus. (C) mCherry expression is lost in terminally differentiated
neurons identiﬁed by the Syn:GFP reporter. mCherryHi NPCs can be differentiated into GFAP+ astrocytes (D) and Tuj1+ neurons (E).
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Pax6). These results indicate that our reporter system can
be combined with additional strategies for speciﬁcally iso-
lating or enriching NSCs including and not limited to: sur-
face marker staining; additional knock-in strategies
conferring NSC or lineage-speciﬁc drug resistance; or
knock-in ﬂuorescent reporters of additional neural lineage
markers. Furthermore, our knock-in line was able to
achieve signiﬁcant enrichment of NSCs with a smaller
subset of surface markers (CD184+CD44-CD271-) as has
been previously used (Yuan et al., 2011), providing a clear
advantage over wild-type hESCs. The potential to replace
the CD24 surface marker with intrinsic ﬂuorescent reporter
activity further provides a means to monitor the NSC cul-
tures and track terminal differentiation. Our lineage-speciﬁc
knock-in approach will enable further studies tracing the
commitment of neural progenitors derived from hESCs; to
perform population based studies; and to improve current
protocols for directed differentiation of cell types needed for
cell replacement therapy.
MATERIALS AND METHODS
Construction of BAC-based targeting vector
The Nestin BAC clone was purchased from Life Technologies Inc.
and the targeting vector was constructed by recombineering as we
previously described (Song et al., 2010).
Cell culture of hESCs
The HUES9 hESCs were cultured as described (Cowan et al.,
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Figure 5. NSC markers map to the mCherryHi Population. Nestin:mCherry NPCs at P0 were stained with isotype control
antibodies or FITC labeled anti-CD44, PE-Cy7 labeled anti-CD24, Alexa-647 anti-CD271 or APC labeled anti-CD184 antibodies.
huES9 ES cells were used as an mCherry negative control. (A) CD184+ cells were gated on CD44-CD24+, while CD184- were gated
on CD24- and both populations were shown relative to the CD184 and mCherry distributions. (B) CD271-CD24- and CD271-CD24+
populations were shown with respect to CD44 and mCherry distributions.
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(MEFs) feeder layer in knockout medium supplemented with 10%
knockout serum replacement, 10% plasmanate, 1 mmol/L gluta-
mine, 0.1 mmol/L nonessential amino acids, 10 ng/mL bFGF, and
0.1 μmol/L β-mercaptoethanol. To passage hESCs, conﬂuent culture
was washed with phosphate buffered saline (PBS), dissociated for
5 min with TrypLE and resuspended into single cells with culture
medium. All tissue culture reagents were purchased from Life
Technologies Inc. except where indicated otherwise.
Differentiation of hESCs into neural progenitors
The neural differentiation of hESCs was performed with established
protocols (Reubinoff et al., 2001; Zhang et al., 2001). Brieﬂy, hESC
colonies were gently scraped from the plate and cultured in sus-
pension as embryoid bodies (EB) on ultra-low cluster plates in EB
formation medium (DMEM/F12-Glutamax, 10% characterized FBS,
1% Pen-Strep, 100 μmol/L β-mercaptoethanol). The media was
changed to NPC induction medium (NPC medium: DMEM/F12-
Glutamax, 0.5% N2, 1% B27, 1% Penicillin-Streptomycin, 10 ng/mL
bFGF). After two days, the EBs were replated onto poly-L-ornithine/
laminin coated plates. After neural cells migrated away from the
EBs and proliferated to conﬂuence, the culture was treated with
0.05% trypsin for 1–2 min at room temperature, resuspended into
single cells, and either sorted or re-plated onto poly-L-ornithine/
laminin coated dishes in NPC medium. In one sort experiment,
BMP inhibitor Noggin (500 ng/mL, R&D Systems) and TGF-beta
inhibitor SB431542 (10 μmol/L, Sigma-Aldrich) were included dur-
ing EB differentiation stages prior to their attachment onto poly-L-
ornithine/laminin coated dishes.
Teratoma formation of hESCs in SCID mice
Two million hESCs were suspended in the knockout medium sup-
plemented with 30% matrigel (BD Biosciences) and injected subcu-
taneously into severe combined immunodeﬁciency (SCID)mice. After
six to eight weeks, teratomas were recovered. For histological
assessment, teratomas were ﬁxed in 10% buffered formalin, embed-
ded in parafﬁn, sectioned and stained with hematoxylin and eosin. To
derive NPCs from teratomas, teratomas were chopped into small
pieces and cultured in NPC medium. After several passages, the
adherent culture became homogenous with mCherry positive cells.
Differentiation of hESC-derived NPCs into mature neurons
The hESC-derived neural progenitors were transduced with lentivi-
rus harboring synapsin promoter-driven EGFP as described (Kim
et al., 2011; Lake et al., 2012). The NPCs were cultured in the
neuronal differentiation medium containing DMEM/F12 supple-
mented with N2/B27, BDNF (10 ng/mL, Peprotech), GDNF (10 ng/
mL, Peprotech), Penicillin-Streptomycin (Invitrogen), glutamax
(Invitrogen), cyclic AMP (1 μmol/L, Sigma Aldrich). The cells were
cultured in differentiation media for two to three weeks with 50% of
the medium replaced every other day.
Quantitative real-time PCR analysis
Total RNA from hESCs and hESC-derived neural cultures were iso-
lated using RNAeasy Mini Kit (QIAGEN) or ZR RNA MicroPrep Kit
(Zymo Research). Total RNA was reverse transcribed using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and
analyzed on a StepOnePlus™ quantitative real-time PCR system
(Applied Biosystems) as previously described (Song et al., 2007). The




GATGGAC), GAPDH (F-GATGACATCAAGAAGGTGGTGA; R-GTC
TACATGGCAACTGTGAGGA). Data analysis was performed using
Microsoft Excel.
Immunoﬂuorescence staining
Neural progenitor cells grown on poly-L-ornithine/laminin coated
4-well chamber plates were ﬁxed in 4% paraformaldehyde for
15 min at room temperature, permeabilized with 0.3% Triton-X-
100 in Triton Buffer Solution (TBS) for 10 min, blocked with 2%
FBS in TBS-0.05% Tween-20 for 20 min and stained with primary
antibodies in blocking buffer at 4°C overnight. Primary antibodies
included: anti-Nestin (611658; BD Pharmingen); anti-SOX2
(561469; BD Pharmingen); anti-RFP (600-401-379; Rockland);
anti-ki67-Alexa ﬂuor-488 (51-9007231; BD Stemﬂow Human
neural Lineage analysis Kit); TuJ1 (MMS-435P, Covance); GFAP
(ab7779, Abcam). The next day, the cells were stained with
secondary antibodies (Alexa ﬂuor 568 donkey anti-rabbit; Alexa
ﬂuor 488 donkey anti-mouse; Life Technologies, Inc.) in blocking
buffer for 45 min and nuclei were counterstained with DAPI.
Images were acquired using an Olympus FV1000 confocal
microscope. Live culture images were also acquired using an
Inverted Axioscope and AxioCam MRm (Carl Zeiss, Inc.). Image
assembly was performed using Adobe Photoshop CS5 (Adobe
Systems, Inc.).
Flow cytometry
hESC-derived neural cultures were washed with PBS, trypsinized
with 0.05% trypsin for 1–2 min at room temperature and resus-
pended into single cells using DMEM/F12 with Glutamax containing
10% FBS. For cell surface staining, cells were incubated with
CD184-APC (560936; BD Pharmingen), CD24-PE-Cy7 (561646; BD
Pharmingen), CD44-PE (51-9007231; BD Pharmingen) and/or
CD271-Alexa ﬂuor 647 or BV421 (560877 or 562562; BD Pharm-
ingen) antibodies in PBS containing 1% bovine serum albumen
(BSA) according to manufacturer’s protocol. Stained and unstained
cells were analyzed using either a BD LSR-II or LSRFortessa ﬂow
cytometry machine (BD Biosciences). Control hES9 hESCs or
hESC-derived NPCs were used for mCherry control and IgG-PE-
Cy7, IgM-FITC, IgG-BV421 and IgG-APC (BD Pharmingen) were
used for isotype controls. Cell sorting was performed using either BD
FACSAria II or BD Inﬂux cell sorter. Gating for all sorts was deﬁned
by isotype control staining. Flow cytometry data analysis was per-
formed using FlowJo software (Tree Star, Inc.).
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Figure 6. mCherryHi-based sorting strategy signiﬁcantly enriches NSCs. (A) Nestin:mCherry NPCs at P0 were stained with
isotype control antibodies or FITC labeled anti-CD44, PE-Cy7 labeled anti-CD24, Alexa-647 anti-CD271 or APC labeled anti-CD184
antibodies. mCherryHi cells were gated on CD271-CD44- or CD44-CD184+ and shown with respect to CD44 and CD24 distributions.
(B) Nestin:mCherry NPCs at P0 were either unstained (Control) or stained with FITC labeled anti-CD44, BV421 labeled anti-CD271
and APC labeled anti-CD184 antibodies. The CD184+CD44- cells (all gating based on isotype control staining) were shown with
respect to mCherry and CD271 distributions. The mCherryHiCD271- population was sorted for gene expression analyses.
(C) mCherryLo (Lo), mCherryHi (Hi), mCherryHi CD184+CD271-CD44- (Hi +) populations were sorted from P0 Nestin:mCherry NPCs
and real time PCR analysis was performed for Sox1, Sox2 and Pax6 expression relative to undifferentiated Nestin:mCherry huES9
hESCs. Results shown are from two independent experiments. *P < 0.05 and **P < 0.01 (two-tailed T-test relative to the mCherryLo
condition).
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